[1]
Ghanchi NK, Shakoor S, Thaver AM, Khan MS, Janjua A, Beg MA. Current situation and challenges in implementing malaria control strategies in Pakistan. Crit Rev Microbiol 2014; 42(4): 588-93.
[2]
Shargie EB, Teshome G, Jeremiah N, et al. Malaria prevalence and mosquito net coverage in Oromia and SNNPR regions of Ethiopia. BMC Public Health 2008; 8(1): 321.
[3]
Wyler DJ. Plasmodium species (malaria). Mandell GL, Douglas
RG, Jr., Bennett JE. Eds. Principles Practice of Infectious Diseases,
Churchill Livingstone Inc., New York, 1990, pp. 2056-2066.
[4]
Nosten F, Ter KF, Maelankiri L, et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. J Infect Dis 1994; 169(3): 595-603.
[5]
Bouvier P, Breslow N, Doumbo O, et al. Seasonality, malaria, and impact of prophylaxis in a West African village. II. Effect on birthweight. Am J Trop Med Hyg 1997; 56(4): 384-9.
[6]
Menendez C, Ordi J, Ismail MR, et al. The impact of placental malaria on gestational age and birth weight. J Infect Dis 2000; 181: 1740-5.
[7]
Van Geertruyden JP, Thomas F, Erhart A, D’Alessandro U. The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg 2004; 71(Suppl. 2): 35-40.
[8]
Newman RD, Parise ME, Slutsker L, Nahlen B, Steketee RW. Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. Trop Med Int Health 2003; 8: 488-506.
[9]
Kramer MS. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ 1987; 65: 663-737.
[10]
McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985; 312: 82-90.
[11]
Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: Cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg 2001; 64: 57-67.
[12]
Nosten F, Rogerson SJ, Beeson JG, McGready R, Mutabingwa TK, Brabin B. Malaria in pregnancy and the endemicity spectrum: what can we learn? Trends Parasitol 2004; 20: 425-32.
[13]
Hommel M. [Morphology, biology and life-cycle of Plasmodium parasites] Bull Acad Natl Med 2007; 191(7): 1235-45; discussion 1245-6
[14]
Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 1998; 68(2)(Suppl.): 447S-63S.
[15]
Good MF, Kaslow DC, Miller LH. Pathways and strategies for developing a malaria blood-stage vaccine. Annu Rev Immunol 1998; 16: 57-87.
[16]
Baloch S, Devrajani BR, Baloch M, Baloch MA. Trace metals concentration in patients with falciparum malaria by atomic absorption spectroscopy. Nat Sci Sleep 2013; 11(4): 65-7.
[17]
Pir MA, Devrajani BR, Baloch S, Baloch M. Serum enzyme activities in patients with vivax malaria and falciparum malaria. Int J Multidiscip Sci Eng 2012; 3(11): 31-4.
[18]
Medica DL, Sinnis P. Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes. Infect Immun 2005; 73(7): 4363-9.
[19]
Garba IH, Gregory U. Serum alkaline phosphatase activity as a potential biomarker for the intergrity of the hepatic drainage system in acute falciparum malaria infection. Int J Infect Dis 2005; 4(2): 13-6.
[20]
Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. P N A S 1979; 76(9): 4258-61.
[21]
Jha S, Shrestha S, Gole SG, Deep G. Assessment of serum bilirubin and hepatic enzymes in malaria patients. Int J Biol Adv Res 2014; 5(3): 160-2.
[22]
D’Souza B, D’Souza V, Swagatha H, Vijayalaxmi K, Namratha AS. Erythrocyte superoxide dismutase and catalase and their correlation with malonedialdehyde in falciparum and vivax malaria. Biomed Res 2009; 20(1): 25-7.
[23]
Garba IH, Gatsing D, Uborn G. Elevated total and isoenzyme forms of acid phosphatase in falciparum malaria. C R Biol 2006; 329(2): 75-8.
[24]
D’Souza B, Parthasarathy R. Sreekantha, D’Souza V. Acid phosphatase as a marker in malaria. Indian J Clin Biochem 2011; 26(4): 396-9.
[25]
Kanwar G, Yadav M, Lepcha L, Kumar S. Elevated serum acid phosphatase: prospective malarial marker. IJRANSS 2014; 2(9): 11-4.
[26]
Álvarez SI, Castañón SG, Ruata MLC, et al. Updating of normal levels of copper, zinc and selenium in serum of pregnant women. J Trace Elem Med Biol 2007; 21(Suppl. 1): 49-52.
[27]
Asaolu MF, Igbaakin PA. Serum levels of micronutrients and antioxidants during malaria in pregnant women in Ado-Ekiti, Ekiti State, Nigeria. Int J Mol Med Sci 2009; 1: 523-6.
[28]
M’boh MG, Yapi FH, Ahiboh HT, Yapo A, Bla BK, Djaman JA. The effect of falciparium malaria infection on the quantity of trace elements (iron, copper, zinc) in the blood in children of Cote d’Ivoire. Agric Biol J N Am 2010; 1(4): 565-70.
[29]
Tholin K, Sandström B, Palm R, Hallmans G. Changes in blood manganese levels during pregnancy in iron supplemented and non-supplemented women. J Trace Elem Med Biol 1995; 9(1): 13-7.
[30]
Innocent O, Ejovi O. Edah, Charles O. Levels of iron and magnesium in serum of Plasmodium falciparum malarial infected children in Abraka, Delta State, Nigeria. J Invest Biochem 2013; 2(1): 62-4.
55
4